UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
Gemvax & Kael said that it presented the results of phase 2 clinical trial ...
by Lee Han-soo
|
2019-12-06 17:06
라인
AbbVie’s Venclexta nears insurance benefit
AbbVie Korea’s Venclexta Tab. (ingredient: venetoclax), a drug for recurren...
by Kim Eun-young
|
2019-12-06 16:35
라인
Syntekabio, CHA Hospital to co-develop immunotherapy
Syntekabio said that it will develop immunotherapy agents jointly with CHA ...
by Lee Han-soo
|
2019-12-06 16:32
라인
Medpacto vows to become global company specializing in biomarker-based drugs
Medpacto, a subsidiary of Theregen ETEX, plans to develop Vactosertib, an i...
by Lee Han-soo
|
2019-12-06 15:03
라인
Petitioner demands broader benefit for ovarian cancer drug Zejula
The government granted insurance benefit to Takeda's ovarian cancer tre...
by Song Soo-youn
|
2019-12-06 15:02
라인
China OKs Humedix's hyaluronic acid filler
Humedix said that China's National Medical Products Administration (NMP...
by Lee Han-soo
|
2019-12-06 15:02
라인
‘Lynparza raises value of precision medicine as anticancer treatment’
AstraZeneca’s Lynparza (ingredient: olaparib), the first PARP (poly ADP rib...
by Kim Yun-mi
|
2019-12-05 16:05
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
Roche Diabetes Care emphasized the importance of “integrated personalized d...
by Park Gi-taek
|
2019-12-05 13:01
라인
‘Obesity treatment will drastically change next few years’
An Irish expert on obesity and diabetes said Wednesday that prospects for t...
by Lee Han-soo
|
2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients'
In Korea, 20.9 percent of diabetic patients, who have a hemoglobin A1c (HbA...
by Lee Han-soo
|
2019-12-04 17:07
라인
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im
|
2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
Hanmi Pharmaceutical said that it has licensed in FLX475, the world’s first...
by Lee Han-soo
|
2019-12-04 16:16
라인
ISU Abxis starts trial of Gaucher disease treatment in Australia
ISU Abxis said that it has started phase 1 clinical trial of Abcertin, an e...
by Lee Han-soo
|
2019-12-04 16:16
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
Samyang Biopharm USA said Tuesday it has signed a deal to adopt a new immun...
by Jeong Sae-im
|
2019-12-03 15:37
라인
Ildong signs co-promotion contract with GSK Consumer Healthcare
Ildong pharmaceutical said that it will co-promote GSK Consumer Healthcare’...
by Lee Han-soo
|
2019-12-03 15:18
라인
Global diabetes group opens 5-day show in Busan
The International Diabetes Federation (IDF) 2019 conference kicked off for ...
by Lee Han-soo
|
2019-12-03 11:04
라인
LG Chem licenses in US firm’s diagnostic platform tech
LG Chem said that it has licensed in a molecular diagnostic platform techno...
by Lee Han-soo
|
2019-12-02 13:42
라인
Syntekabio views industry’s crisis as opportunity
Syntekabio said that it aims to become the world's first publicly-trade...
by Jeong Sae-im
|
2019-11-29 17:54
라인
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
S. Biomedics said that the Ministry of Food and Drug Safety has approved a ...
by Lee Han-soo
|
2019-11-29 15:42
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
Daewoong Pharmaceutical said its new drug Fexuprazan will challenge the pot...
by Jeong Sae-im
|
2019-11-29 15:23
-
1
2
3
4
5
6
7
8
9
10
다음
-
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
'Insulin is safe, natural replacement therapy for diabetic patients'
3
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
4
Samyang Biopharm’s US subsidiary to work on new immunotherapy
5
Swedish researchers divide Type 2 diabetes into 5 subgroups
6
Ildong signs co-promotion contract with GSK Consumer Healthcare
7
Korean patient with rare breast cancer to sue Allergan in US
8
Korea exports health insurance system to Bahrain
9
Quick test for meningitis unavailable due to low reimbursement
10
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top